Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of the strategy on early outcome
Antonio M. Calafiore(Henry Dunant Hospital), Stefano D’Alessandro(University of Chieti-Pescara), Antonio Bivona(Essex Cardiothoracic Centre), Gabriele Di Giammarco(University of Chieti-Pescara), Rocco Carella(University of Chieti-Pescara), Giuseppe Vitolla(University of Chieti-Pescara), Michele Di Mauro(University of Foggia), Marco Contini(University of Catania), Marco Pano(University of Chieti-Pescara)
Cited by 152
Related Papers
Mitral Valve Surgery for Functional Mitral Regurgitation: Should Moderate-or-More Tricuspid Regurgitation Be Treated? A Propensity Score Analysis
|The Annals of Thoracic Surgery|2009|163
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study
|The Lancet Respiratory Medicine|2022|81
Does Off-Pump Coronary Surgery Reduce Postoperative Acute Renal Failure? The Importance of Preoperative Renal Function
|The Annals of Thoracic Surgery|2007|74
Mitral valve surgery for functional mitral regurgitation: prognostic role of tricuspid regurgitation☆
|European Journal of Cardio-Thoracic Surgery|2009|74
Management of Patients With Severe Mitral Annular Calcification
|Journal of the American College of Cardiology|2022|68